StockData
Nasus Pharma Ltd logo

Nasus Pharma Ltd (NSRX) stock

NSRXNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Mar 25, 2026Score 6/30
$2.70+0.09 (+3.45%)

Close on Nov 18, 2026Market cap $24.34MP/E –Yield –

Nasus Pharma net income

Net income is the profit left for shareholders after every expense, interest and tax.

For fiscal 2025 it was -$5.86M.

Annual net income

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$5.86M–
FY2024Dec 31, 2024-$1.53M–
FY2023Dec 31, 2023-$1.05M–

More Nasus Pharma figures

See a number that looks wrong?